Sleep quality among psoriasis patients: excluding the immunosuppressive therapy effect

Abstract Background Psoriasis is associated with several comorbidities and different psychological disorders including anxiety depression. may also affect sleep quality consequently the of life. The use immunosuppressants used in treatment psoriasis were reported to increase insomnia, so purpose study assess degree insomnia patients not on any systemic or immunosuppressive therapy compared controls examine relation between quality, depressive, symptoms. One hundred cases, receiving therapy, 80 apparently healthy subjects recruited as controls. We assessed sleep, screened for depressive symptoms among controls; patient immunosuppressant was excluded. Results Quality using Pittsburgh Sleep Index, Insomnia Severity depression Beck Depression Inventory, Taylor Anxiety Manifest Scale statistically significant higher than all p value < 0.001. Depressive significantly positively correlated Index (PSQI) global score ( = 0.045) subjective subscale 0.005). Also, BDI scores measured by ISI 0.026). PSQI 0.004) its (subjective latency, disturbance, medications daytime dysfunction) 0.001). Conclusions Abnormal detected this could be due disease itself psoriasis. Screening psychiatric specially that depression, anxiety, utmost importance better Thus, collaboration dermatologists psychiatrists show life these cases outcomes.